SLC27A5 and hepatocellular carcinoma: Collectively, our results implicate SLC27A5 and tyrosine-metabolizing enzymes as acting as tumor suppressor in HCC and coordinating lipid and tyrosine metabolism, which may be potential targets in HCC treatment.